|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000016662 |
|
Date of registration:
|
27/02/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Prognostic value of tubulointerstitial lesions, urinary N-acetyl-B-D-glucosaminidase, and urinary B2-microgrobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
|
|
Scientific title:
|
Prognostic value of tubulointerstitial lesions, urinary N-acetyl-B-D-glucosaminidase, and urinary B2-microgrobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. - Tubulointerstitial lesions and urinary biomarkers |
|
Date of first enrolment:
|
2015/01/17 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019339 |
|
Study type:
|
Observational |
|
Study design:
|
Not selected Not selected
|
|
Phase:
|
Not selected
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Koki Mise |
|
Address:
|
1-3-1, Kajigaya, Takatu-ku, Kawasaki-shi, Kanagawa-ken, 213-0015, Japan
Japan |
|
Telephone:
|
044-877-5111 |
|
Email:
|
kokims-frz@umin.ac.jp |
|
Affiliation:
|
Toranomon Hospital Kajigaya Nephrology Center |
|
|
Name:
|
Yoshifumi Ubara |
|
Address:
|
1-3-1, Kajigaya, Takatu-ku, Kawasaki-shi, Kanagawa-ken, 213-0015, Japan
Japan |
|
Telephone:
|
044-877-5111 |
|
Email:
|
ubara@toranomon.gr.jp |
|
Affiliation:
|
Toranomon Hospital Kajigaya Nephrology Center |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Patients in whom urinary NAG and B2-MG were not examined at the time of renal biopsy Patients whose baseline eGFR was <10 mL/min/1.73m2
Age minimum:
18years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetic nephropathy
|
|
Primary Outcome(s)
|
|
A decline of eGFR by at least 50% from baseline or commencement of dialysis due to end-stage renal disease
|
|
Source(s) of Monetary Support
|
|
Okinaka Memorial Institute for Medical Research
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|